Oncolytics Biotech Inc. Made Headway
Tue, Dec 31, 2019 at 05:30 PM
Oncolytics Biotech Inc. (ONCY:NASDAQ) shot up at $4.76, a gain of 23%. On Mon 30 Dec 19, ONCY:NASDAQ touched a New 2-Week High of $3.87. The stock got featured on our News Catalysts scanner on Thu 12 Dec 19 at 07:58 AM in the 'BIOTECH' category. From Mon 09 Dec 19, the stock recorded 57.14% Up Days and 53.33% Green Days
About Oncolytics Biotech Inc. (ONCY:NASDAQ)
Oncolytics Biotech Inc is a development stage biopharmaceutical company. It is engaged in the discovery and development of pharmaceutical products for the treatment of cancer that have not been successfully treated with conventional therapeutics.
Top 10 Gainers:
- Spirit Realty Capital, Inc. (SRC:NYSE), 66.67%
- FuelCell Energy, Inc. (FCEL:NASDAQ), 49.4%
- Viveve Medical, Inc. (VIVE:NASDAQ), 46.51%
- Inpixon (INPX:NASDAQ), 43.61%
- BioXcel Therapeutics, Inc. (BTAI:NASDAQ), 40.35%
- Neovasc Inc. (NVCN:NASDAQ), 36.96%
- Mereo BioPharma Group plc (MREO:NASDAQ), 32.26%
- Lincoln Educational Services Corporation (LINC:NASDAQ), 25%
- Jaguar Health, Inc. (JAGX:NASDAQ), 23.02%
- Oncolytics Biotech Inc. (ONCY:NASDAQ), 23%